학술논문
EVOKE-01: A phase 3 study of sacituzumab govitecan (SG) versus docetaxel in patients with non-small cell lung cancer (NSCLC) progressing on or after platinum-based chemotherapy and checkpoint inhibitors.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755